25 – Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production solutions, today announced they have signed a Memorandum Of Understanding to start a strategic partnership aimed at advancing industrial-scale production of Astatine-211 (211At), an alpha-emitting radioisotope across Europe and the United States.
SHARE
See More
3th GLOBAL MEETING WG & Core Group meeting of the COST Action CA19114 Network for Optimized Astatine Labeled Radiopharmaceuticals minutes:
This international Meeting, fully dedicated to astatine-211, aims to convene actors from around the world while emphasizing sustainable practices. These three days will offer a comprehensive overview of the accomplishments made over the past four years within this European network comprising academic and industrial stakeholders. Bringing together 150 participants from Europe, America, and Asia representing...
NOMATEN Centre of Excellence, organizes the International Radiopharmaceutical Conference NOMRad which will be held 25-27 June 2024 in Warsaw, Poland. The conference will focus on topics related to radiopharmaceuticals development, including production of medical radioisotopes, new labelling methods and preclinical and clinical radiopharmaceuticals’ evaluation. There will be also presented talks on astatine production and studies...
